Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients

Cancer

Volumn 106, Issue 4, 2006, Pages 966-973

  Wolf, Ido ^a,b   Sadetzki, Seigal ^b,c   Kanely, Hannah ^a   Kundel, Yulia ^a   Pariente, Clara ^a   Epstein, Nava ^a   Oberman, Bernice ^c   Catane, Raphael ^a,b   Kaufman, Bella ^a   Shimon, Ilan ^b,d  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

Author keywords

Adipocytokines; Adiponectin; Breast cancer; Cancer cachexia; Colon cancer; Ghrelin; Leptin

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; LEPTIN; SERUM ALBUMIN;

ADIPOSE TISSUE; ADULT; AGE DISTRIBUTION; AGED; ANOREXIA; ARTICLE; BODY WEIGHT; BREAST CANCER; CACHEXIA; CANCER PATIENT; CANCER THERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; COLON CANCER; CONTROLLED STUDY; FEMALE; GENDER; HORMONE BLOOD LEVEL; HUMAN; MALE; METASTASIS; MUSCLE MASS; PATHOGENESIS; PRIORITY JOURNAL; WEIGHT REDUCTION;

ADIPONECTIN; AGED; BREAST NEOPLASMS; CACHEXIA; COLONIC NEOPLASMS; FEMALE; HUMANS; LEPTIN; MALE; MIDDLE AGED; PEPTIDE HORMONES; SEX FACTORS; WEIGHT LOSS;

EID: 32544440799     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.21690     Document Type: Article

References (47)

1. Tisdale MJ. Cachexia in cancer patients. Nat Rev Cancer. 2002;2:862-871.
2. Chamberlain JS. Cachexia in cancer-zeroing in on myosin. N Engl J Med. 2004;351:2124-2125.
3. Rubin H. Cancer cachexia: its correlations and causes. Proc Natl Acad Sci USA. 2003;100:5384-5389.
4. Acharyya S, Ladner KJ, Nelsen LL et al. Cancer cachexia is regulated by selective targeting of skeletal muscle gene products. J Clin Invest. 2004;114:370-378.
5. Ramos EJ, Suzuki S, Marks D, Inui A, Asakawa A, Meguid MM. Cancer anorexia-cachexia syndrome: cytokines and neuropeptides. Curr Opin Clin Nutr Metab Care. 2004;7:427-434.
6. Havel PJ. Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood). 2001;226:963-977.
7. Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511-1525.
8. Diez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148:293-300.
9. Berg AH, Combs TP, Scherer PE. ACRPSO/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84-89.
10. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257:79-83.
11. Staiger H, Tschritter O, Machann J, et al. Relationship of serum adiponectin and leptin concentrations with body fat distribution in humans. Obes Res. 2003;11:368-372.
12. Pannacciulli N, Vettor R, Milan G, et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab. 2003;88:1748-1752.
13. Yang WS, Lee WJ, Funahashi T, et al. Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J Clin Endocrinol Metab. 2001;86:3815-3819.
14. Spranger J, Kroke A, Mohlig M, et al. Adiponectin and protection against Type 2 diabetes mellitus. Lancet. 2003;361:226-228.
15. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941-946.
16. Dal Maso L, Augustin LS, Karalis A et al. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab. 2004;89:1160-1163.
17. Miyoshi Y, Funahashi T, Kihara S, et al. Association of serum adiponectin levels with breast cancer risk. Clin Cancer Res. 2003;9:5699-5704.
18. Mantzoros C, Petridou E, Dessypris N et al. Adiponectin and breast cancer risk. J Clin Endocrinol Metab. 2004;89:1102-117.
19. Ishikawa M, Kitayama J, Kazama S, Hiramatsu T, Hatano K, Nagawa H. Plasma adiponectin and gastric cancer. Clin Cancer Res. 2005;11:466-472.
20. Jamieson NB, Brown DJ, Michael Wallace A, McMillan DC. Adiponectin and the systemic inflammatory response in weight-losing patients with nonsmall cell lung cancer. Cytokine. 2004;27:90-92.
21. Wang B, Jenkins JR, Trayhurn P. Expression and secretion of inflammation-related adipokines by human adipocytes differentiated in culture: Integrated response to TNF-α Am J Physiol Endocrinol Metab. 2005;288:E731-E740.
22. Kojima M, Hosoda H, Date Y, et al.: Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402:656-660.
23. Gualillo O, Lago F, Gomez-Reino J, Casanueva FF, Dieguez C. Ghrelin, a widespread hormone: insights into molecular and cellular regulation of its expression and mechanism of action. FEBS Lett. 2003;552:105-109.
24. Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab. 2000;85:4908-4911.
25. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908-913.
26. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
27. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992-5995.
28. Tschop M, Weyer C, Tataranni PA, et al. Circulating ghrelin levels are decreased in human obesity. Diabetes. 2001;50:707-709.
29. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87:240-244.
30. Cummings DE, Weigle DS, Frayo RS, et al.: Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
31. Nagaya N, Uematsu M, Kojima M, et al.: Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors. Circulation. 2001;104:2034-2038.
32. Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145:669-673.
33. Shimizu Y, Nagaya N, Isobe T, et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res. 2003;9:774-778.
34. Garcia JM, Garcia-Touza M, Hijazi RA, et al. Active ghrelin levels and active/total ghrelin ratio in cancer-induced cachexia. J Clin Endocrinol Metab. 2005;90:2920-2926.
35. Neary NM, Small CJ, Wren AM, et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:2832-2836.
36. Wolfe BE, Jimerson DC, Orlova C, Mantzoros CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteers. Clin Endocrinol (Oxf). 2004;61:332-338.
37. Brichard SM, Delporte ML, Lambert M. Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res. 2003;35:337-342.
38. Schulze PC, Kratzsch J, Linke A et al. Elevated serum levels of leptin and soluble leptin receptor in patients with advanced chronic heart failure. Eur J Heart Fail. 2003;5:33-40.
39. Brown DR, Berkowitz DE, Breslow MJ. Weight loss is not associated with hyperleptinemia in humans with pancreatic cancer. J Clin Endocrinol Metab. 2001;86:162-166.
40. Wallace AM, Kelly A, Sattar N, McArdle CS, McMillan DC. Circulating concentrations of "free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients. Nutr Cancer. 2002;44:157-160.
41. Bolukbas FF, Kilic H, Bolukbas C, et al. Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer. 2004;4:29.
42. Fleming ID, Cooper JS, Henson DE, editors. American Joint Committee on Cancer Staging Manual. 5th edition. Philadelphia: Lippincott-Raven, 1997.
43. Bruun JM, Lihn AS, Verdich C, et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab. 2003;285:E527-E533.
44. Dulger H, Alici S, Sekeroglu MR et al. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Int J Clin Pract. 2004;58:545-549.
45. Arpaci F, Yilmaz MI, Ozet A, et al. Low serum leptin level in colon cancer patients without significant weight loss. Tumori. 2002;88:147-149.
46. Simons JP, Schols AM, Campfield LA, Wouters EF, Saris WH. Plasma concentration of total leptin and human lung-cancer-associated cachexia. Clin Sci (Lond). 1997;93:273-277.
47. Casabiell X, Pineiro V, Peino R, et al. Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men. J Clin Endocrinol Metab. 1998;83:2149-2155.